Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study finds striking variations in SARS-CoV-2-related mortalities in North and South regions of the USA

Study finds striking variations in SARS-CoV-2-related mortalities in North and South regions of the USA

Study proposes structural explanation for immune evasion effect of SARS-CoV-2 BA.2 variant mutations S371L/F

Study proposes structural explanation for immune evasion effect of SARS-CoV-2 BA.2 variant mutations S371L/F

SARS-CoV-2 protein interactions with viral and host RNAs in authentic virus-infected cells

SARS-CoV-2 protein interactions with viral and host RNAs in authentic virus-infected cells

Recombinant adenovirus vector vaccine generates mucosal antibodies against SARS-CoV-2

Recombinant adenovirus vector vaccine generates mucosal antibodies against SARS-CoV-2

Biophysical fitness profile of SARS-CoV-2 Delta variant

Biophysical fitness profile of SARS-CoV-2 Delta variant

Encouraging in vitro results with SARS-CoV-2-spike-specific polyclonal antibody fragments

Encouraging in vitro results with SARS-CoV-2-spike-specific polyclonal antibody fragments

Mechanisms leading to Parkinson's disease following SARS-CoV-2 infection

Mechanisms leading to Parkinson's disease following SARS-CoV-2 infection

COVID-19 severity is correlated with body composition

COVID-19 severity is correlated with body composition

Novel respiratory model predicts mechanisms altered by SARS-CoV-2 variants

Novel respiratory model predicts mechanisms altered by SARS-CoV-2 variants

Breakthrough SARS-CoV-2 infection peaks at 5 months

Breakthrough SARS-CoV-2 infection peaks at 5 months

Researchers create model to explore SARS-CoV-2 Omicron and Delta supremacy

Researchers create model to explore SARS-CoV-2 Omicron and Delta supremacy

Assessing COVID-19 vaccination preferences of younger adults in Canada

Assessing COVID-19 vaccination preferences of younger adults in Canada

Histopathologic and molecular effects in the placenta after SARS-CoV-2 infection during pregnancy

Histopathologic and molecular effects in the placenta after SARS-CoV-2 infection during pregnancy

Immunity before and after the SARS-CoV-2 Omicron variant in South Africa

Immunity before and after the SARS-CoV-2 Omicron variant in South Africa

Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response

Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.